The Limited Times

Now you can see non-English news...

HSV board member Wüstefeld resigns: Boldt manages business

2022-09-29T03:42:04.931Z


HSV board member Wüstefeld resigns: Boldt manages business Created: 2022-09-29Updated: 2022-09-29 05:37 Thomas Wüstefeld on the phone. © Christian Charisius/dpa/archive image Chief Financial Officer Thomas Wüstefeld has announced his resignation from the second division soccer team Hamburger SV. In an extraordinary meeting of the supervisory board, the 53-year-old informed "that he is resigning


HSV board member Wüstefeld resigns: Boldt manages business

Created: 2022-09-29Updated: 2022-09-29 05:37

Thomas Wüstefeld on the phone.

© Christian Charisius/dpa/archive image

Chief Financial Officer Thomas Wüstefeld has announced his resignation from the second division soccer team Hamburger SV.

In an extraordinary meeting of the supervisory board, the 53-year-old informed "that he is resigning from his supervisory board position with immediate effect and thus also from his interim role as a board member," HSV announced on Wednesday evening.

Hamburg – The supervisory board accepted the decision and decided that sports director Jonas Boldt “will initially lead the operative business of HSV as the sole director”.

"I am aware of the responsibility and will tackle the upcoming tasks in very close cooperation with my colleagues in the office as well as with the Supervisory Board and especially with the Finance Committee," Boldt was quoted as saying in the press release.

Several allegations had been made against the medical entrepreneur Wüstefeld in the past few weeks.

He denied a report about alleged illegal drug deals.

"I can assure you that there is nothing to it," he said recently, pointing out: "There is a campaign by competitors behind it."

The news magazine "Spiegel" reported that Wüstefeld started manufacturing cannabis products three years ago and offered oils containing cannabidiol as medical products.

The Hamburg authority for justice and consumer protection checked whether the sale could have been illegal.

The drugs are said to have come on the market via a Luxembourg company.

In 2020, according to the report, the authorities there banned distribution and ordered a recall.

Swiss control authorities also found that the products “do not meet the basic requirements for medical devices,” it said.

dpa

Source: merkur

All news articles on 2022-09-29

You may like

Trends 24h

Latest

© Communities 2019 - Privacy

The information on this site is from external sources that are not under our control.
The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.